Semaglutide Cuts Heart Attack Risk Even Without Weight Loss, Study Shows

Semaglutide Cuts Heart Attack Risk Even Without Weight Loss, Study Shows

Credit: Canva

Text

Updated Feb 15, 2026 | 03:49 PM IST

SummaryResearchers from University College London (UCL) have found that taking semaglutide drugs such as Ozempic, Wegovy, Rybelsus can reduce the risk of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) by four percent for every 5kg less body weight or 5cm smaller waist

End of Article